11 Most Buzzing Stocks to Buy with the Highest Upside Potential

9. NeoGenomics Inc. (NASDAQ:NEO)

NeoGenomics Inc. (NASDAQ:NEO) is one of the most buzzing stocks to buy with the highest upside potential. On February 25, NeoGenomics officially launched RaDaR ST, a tumor-informed circulating tumor DNA/ctDNA assay designed to detect molecular residual disease/MRD across various solid tumor types. This launch targets a rapidly growing MRD market estimated at over $20 billion, which NeoGenomics believes is currently less than 10% penetrated. By providing patient-specific molecular insights, the test allows clinicians to identify residual disease and recurrence earlier than traditional imaging, facilitating more timely treatment interventions.

The RaDaR ST assay uses whole-exome sequencing and advanced bioinformatics to track up to 48 tumor-specific variants. It features a high level of sensitivity, with a limit of detection at 95% probability of 11 parts per million/ppm, ensuring the identification of trace amounts of tumor DNA. The test has been validated through clinical and real-world data in several areas, including breast and head & neck cancers, and has already received Medicare approval for its initial launch indications.

With the introduction of RaDaR ST, NeoGenomics Inc. (NASDAQ:NEO) expands its oncology portfolio to cover the full continuum of cancer care, from initial diagnostic profiling to long-term surveillance. The CEO noted that this advancement reflects the company’s commitment to precision medicine and its investment in technologies that address unmet clinical needs.

NeoGenomics Inc. (NASDAQ:NEO) operates a network of cancer-focused testing laboratories in the US and the UK. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories.